Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-108

Fairly disappointing update. Feels like they've essentially kicked the can down the road. What happened to 'coming weeks'?

The one facet of discussion that this update has clearly addresses is 'fully funded trials'. The amount raised last time via the CR means that it might not be fully funded at the current cash burn rate, which is really disappointing. It looks like a CR/SPP to the keep the lights on until the next Government Rebate, then possibly a further CR / SPP to fund further phase 2 or (hopefully) phase 3 testing (phase 3 could be significantly dilutionary event, if it is 20 - 50/100 million is required by shareholders as quoted by a few commentators on here).